Decision Support in Ohio

DiaPharma Group, Inc. manufactures specialty research and clinical assay kits, reagents, and hemostasis analyzers for bleeding/clotting disorders, thrombosis, liver disease, drug-induced organ injury, and anti-cancer drug development. Founded in 1997, the company employs scientists with expertise in hemostasis, coagulation testing, platelet function analysis, fibrosis biomarkers, and NETosis research. DiaPharma offers chromogenic substrates, ADAMTS13 assays, Factor X testing, and mechanistic biomarkers for MASH, alcoholic liver disease (ALD), and drug-induced liver injury (DILI). The company provides personalized scientific support and customer service to clinical laboratories, research institutions, and pharmaceutical development teams.

Hyland Software is a global enterprise content management (ECM) and process management platform provider headquartered in Westlake, Ohio. The company delivers AI-enabled Content Innovation Cloud solutions that help healthcare systems, payers, financial services, insurance, government, and other enterprises manage documents, workflows, and enterprise imaging. Key offerings include OnBase (document handling and workflow automation), Perceptive Content, Alfresco (open-source content services with DOD 5015.02 certification), and Nuxeo (digital asset and content management). Hyland's healthcare-specific solutions address clinical care (patient records, consent management, enterprise imaging), payers (member experience, workflow automation), and back-office operations. The platform integrates with core systems, leverages AI for content intelligence and agentic document processing, and supports governed automation across regulated industries. With 3,750+ employees and presence in 25+ countries, Hyland serves more than half of the Fortune 100.

Great Lakes NeuroTechnologies (GLNT) is a biomedical technology company specializing in physiological monitoring systems and patient-centered diagnostic platforms for movement disorders, telemedicine, and in-home health monitoring. Founded in 2010 and based in Independence, Ohio, GLNT designs, manufactures, and distributes wireless and web-based bioinstrumentation products for clinical, research, and educational applications. The company's primary offerings include the Kinesia line of wearable systems for real-time motor symptom assessment in Parkinson's disease and essential tremor, and the BioRadio wireless data acquisition platform for research and education. GLNT holds over 50 patents in neurological and movement disorder monitoring, with recent innovations in AI-driven therapy adjustment and remote deep brain stimulation (DBS) programming. The company serves physicians, medical technicians, healthcare practitioners, researchers, universities, and hospitals, addressing clinical needs in remote patient monitoring, clinical trial management, and therapy optimization.